PKM2 Under Hypoxic Environment Causes Resistance to mTOR Inhibitor in Human Castration Resistant Prostate Cancer

Oncotarget- United States

doi 10.18632/oncotarget.25498

Full Text

Abstract

Available in

Categories

Date

May 18, 2018

Authors

Koshiro Nishimoto

Publisher

Impact Journals, LLC

Related search

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology

English

Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer

English

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy

English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology

English

PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells

Cellular Physiology and Biochemistry

English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology

English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research

Cancer Research

English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research

Cancer Research

English

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology

English